Serum lipoprotein (a) in renal transplant recipients receiving cyclosporin monotherapy

Nephrology Dialysis Transplantation

Volumn 8, Issue 9, 1993, Pages 863-867

  Short, C D ^a   Brown, J H ^a   Anwar, N ^a   Bhatnager, D ^a   Mackness, M I ^a   Durrington, P N ^a   Hunt, L P ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Coronary heart disease; Cyclosporin; Hyper lipidaemia; Lipoprotein Lp(a); Renal transplantation

Indexed keywords

CHOLESTEROL; CYCLOSPORIN A; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROMA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DRUG BLOOD LEVEL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CYCLOSPORINE; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0027368658     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a092611     Document Type: Article

References (32)

1. Raine AEG, MacMahon SH, Selwood NH, Wing AJ, Brunner FP. Mortality from myocardial infarction in patients on renal replacement therapy in the UK. Nephrol Dial Transplant 1991; 6: 902
2. Mahony JF. Longterm results and complications of transplantation: the kidney. Transplant Proc 1989; 21: 1433-1434
3. Short CD, Durrington PN. Hyperlipidaemia in renal disease. Clin Endocrinol Metab 1990; 4(4): 777-806
4. Gokal R, Mann JI, Moore RA, Morris PJ. Hyperlipidaemia following renal transplantation. Q J Med 1979; 48: 507-517
5. Harris KPG, Russell GI, Parvin SD, Veitch PS, Walls J. Alterations in lipid and carbohydrate metabolism due to cyclosporine A in renal transplant recipients. Br Med J 1986; 292: 16
6. Gonazalez-Gronow M, Edelberg JM, Pizzo SM. Further characterisation of the cellular plasminogen binding sites: evidence that plasminogen 2 and lipoprotein(a) compete for the same site. Biochemistry 1989; 28: 2374-2377
7. Smith EB, Cochran S. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein II: preferential immobilisation of lipoprotein(a) [Lp(a)]. Atherosclerosis 1990; 84: 173-.
8. Rhoads GG, Dahler G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540-2544
9. Anwar N, Short CD, Durrington PN, Khan A, Bhatnager D, Gokal R. Raised serum apolipoprotein levels in CAPD and renal transplant patients. Nephrol Dial Transplant 1991; 6(10): 838
10. Cuxart M, Sans R, Vicente M et al. Lipoprotein(a) in patients with chronic renal insufficiency on hemodialysis. Med Clin (Bare) 1989; 92: 769-771
11. Karadi I, Romics L, Palos G et al. Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem 1989; 35: 2121-2123
12. Short CD, Anwar N, Durrington PN et al. Serum lipoprotein(a) levels in nephrotic syndrome, CAPD patients and renal transplant recipients. Atherosclerosis 1991; 90: 225
13. Johnson RWG, Wise MH, Bakran A et al. A four year prospective study of cyclosporin and cadaver renal transplantation. Transplant Proc 1985; 17: 1197-1200
14. Mackness MI, Durrington PN. Lipoprotein separation and analysis for clinical studies. In Converse CA, Skinner ER, ed. Lipoprotein analysis: a Practical Approach. Oxford University Press, Oxford 1992: 1-42
15. Adolphson JL, Albers JJ. Comparison of two nephelometric methods for apoprotein Al and apoprotein B with standardised apoprotein Al and B radioimmunoassays. J Lipid Res 1989; 30: 597
16. Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnager D. Apolipoprotein(a), Al and B and parental history in men with early onset ischaemic heart disease. Lancet 1988; 1: 1070-1073
17. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904-910
18. Scanu AM, Fless GM. Lipoprotein(a). Heterogeneity and biological relevance. J Clin Invest 1990; 85: 1709-1715
19. Kasiske BL, Umen AJ. Persistent hyperlipidemia in renal transplant patients. Medicine 1987; 66: 309-316
20. Vatsala A, Weinburg RB, Schoenberg L et al. Lipid abnormalities in cyclosporine-prednisolone treated renal transplant recipients. Transplantation 1989; 48: 37-43
21. Raine AEG, Carter R, Mann JI, Morris PJ. Adverse effects of cyclosporin on plasma cholesterol in renal transplant recipients. Nephrol Dial Transplant 1988; 3: 458-463
22. Alpers JJ, Taggart HM, Appelbaum-Bowden D, Haffner S, Chesnut CH, Hazard WR. Reduction of LCAT, Apo D and the Lp(a) lipoprotein with the anabolic steroid stanazolol. Biochim Biophys Acta 1984; 795: 293-297
23. Crook D, Sidhu M, Seed M, O'Donnell M, Stevenson JC. Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis 1992; 92: 41-47
24. Murphy BG, McNamee PT. Apolipoprotein (a) concentrations decrease following renal transplantation. Nephrol Dial Transplant 1992; 7: 174-175
25. Brown CD, Azrolan N, Marlcell M, Zhao ZH, Thomas L, Friedman EA. Assessment of lipoprotein(a) levels in normo- and hypercholesterolemic renal transplant recipients. J Am Soc Nephrol 1991; 2(3): 793
26. MBewu AD, Bhatnagar D, Mackness M et al. Serum lipoprotein in hetrozygotes for familial hypercholesterolaemia, their relatives and controls. Atherosclerosis 1991; 11: 940-946
27. Hassted SJ, Williams RR. Three alleles for quantitative Lp(a). Genet Epidemiol 1986; 3: 53-55
28. Rees A, Bishop A, Morgan R. The Apo(a) gene: structure/function relationships and the possible link with atheromatous disease. Br Med Bull 1990; 46: 873-890
29. Kehely A, Barbir M, Tamugar E et al. High prevalence of raised levels of Lp(a) and apoB after cardiac transplantation. Atherosclerosis 1990; 85: 97
30. Grossmann RM, Delaney RJ, Brintow EA, Carter DM, Gottlieb AB. Hyperglyceridemia in patients with psoriasis treated with cyclosporine. J Am Acad Dermatol 1991; 25: 648-651
31. Ballantyne CM, Podet EJ, Patsch WP et al. Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA 1989; 262: 53-56
32. Rath M, Niendorf A, Reblin T, Dietel M, Krebber H-J, Beisegel U. Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Atherosclerosis 1989; 9: 579-592